| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |